drugset / Trial / NCT00656110

Neuroma Injections to Treat Restless Legs Syndrome - RCT

NCT00656110

Unknown 60 enrolled Lowcountry Infectious Diseases
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether, in a randomized, placebo-controlled trial, restless legs syndrome (RLS) can be caused by pinched and damaged foot nerves called neuromas.

Timeline

Start
2008-04
Primary completion
2009-11
Completion
2009-12

Publications

  • Background Lettau LA, Gudas CJ. Bilateral Morton's neuromas as an etiology of restless legs syndrome. Journal of the South Carolina Medical Association 101: e341-e347, 2005

Drugs

EvaluationDrugModalityDoseRoute
Subject Absolute Alcohol Unknown 4 % Other
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Lidocaine Other / unclassified 2 % Other
Subject Methylprednisolone Other / unclassified 0.8 mg Other